Michael Dybbs

Insider Reports History

Location
C/O New Leaf Venture Partners, 1200 Park Place, Suite 300, San Mateo, CA
Signature
/s/ David Pauling as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Dybbs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUTRO BIOPHARMA, INC. Director Stock Option (right to buy) 50K Jun 6, 2025 Direct
Nkarta, Inc. Director Stock Option (right to buy) 46K Jun 5, 2025 Direct
Kalaris Therapeutics, Inc. Director Stock Option (Right to Buy) 18K Apr 10, 2025 Direct

Insider Reports Filed by Michael Dybbs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STRO SUTRO BIOPHARMA, INC. Jun 6, 2025 1 $0 4 Jun 10, 2025 Director
NKTX Nkarta, Inc. Jun 5, 2025 1 $0 4 Jun 9, 2025 Director
KLRS Kalaris Therapeutics, Inc. Apr 10, 2025 1 $0 4 Apr 11, 2025 Director
KLRS Kalaris Therapeutics, Inc. Mar 18, 2025 0 $0 3 Mar 18, 2025 Director
NKTX Nkarta, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
STRO SUTRO BIOPHARMA, INC. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
STRO SUTRO BIOPHARMA, INC. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
NKTX Nkarta, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
NKTX Nkarta, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
STRO SUTRO BIOPHARMA, INC. Jun 6, 2022 1 $0 4 Jun 8, 2022 Director
NKTX Nkarta, Inc. Jun 13, 2021 1 $0 4 Jun 15, 2021 Director
STRO SUTRO BIOPHARMA, INC. Jun 3, 2021 1 $0 4 Jun 7, 2021 Director